Public health researchers in the United Kingdom have launched a new national study to investigate long-term immune memory following COVID-19 vaccination, aiming to inform future vaccine strategies and booster policies.
Large-scale cohort to track antibody and cellular responses
The study will recruit a large cohort of adults who have received primary COVID-19 vaccination courses and will follow participants over multiple years to measure both antibody titres and T-cell responses. Researchers intend to assess how immune memory wanes or persists over time, and how this correlates with protection against infection and severe disease.
Study design and objectives
Participants will provide periodic blood samples, complete health questionnaires and report any breakthrough infections. The research team will compare immune profiles across different vaccine types, age groups and individuals with prior SARS-CoV-2 infection. Results are expected to help refine timing of booster doses and identify populations who may benefit from targeted immunisation strategies.
Implications for UK vaccine policy and international relevance
Findings from the study could influence UK vaccination recommendations, particularly regarding booster scheduling for older adults and immunocompromised individuals. Internationally, better understanding of immune memory will assist global health bodies in planning long-term COVID-19 control measures.
Researchers emphasise that the study complements ongoing surveillance work and will integrate with existing datasets to maximise public health impact. Further details on recruitment and collaboration will be published by participating institutions.
For updates on the study and related research, see the participating institutions’ announcements.
